Patents by Inventor Randy Talbott

Randy Talbott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • P53 response genes
    Patent number: 5886149
    Abstract: This present invention concerns polypeptide molecules comprising human p53 response protein PIGI-1.
    Type: Grant
    Filed: November 20, 1996
    Date of Patent: March 23, 1999
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Leonard Buckbinder, Randy Talbott, Bernd R. Seizinger, Nikolai Kley
  • Isolation of novel HIV-2 proviruses
    Patent number: 5883081
    Abstract: Novel HIV-2 proviruses, molecular clones, nucleic acids, polypeptides, viruses and viral components are described. The use of these compositions as components of diagnostic assays, as immunological reagents, as vaccines, as components of packaging cells, cell transduction vectors, and as gene therapy vectors is also described.
    Type: Grant
    Filed: June 7, 1996
    Date of Patent: March 16, 1999
    Assignee: The Regents of the University of California
    Inventors: Gunter Kraus, Flossie Wong-Staal, Randy Talbott, Eric M. Poeschla
  • P53 response genes
    Patent number: 5667987
    Abstract: Nucleic acid sequences, particularly DNA sequences, coding for all or part of p53 response protein PIGI-1, expression vectors containing the DNA sequences, host cells containing the expression vectors, and methods utilizing these materials are disclosed. The invention also concerns polypeptide molecules comprising all or part of p53 response protein PIGI-1, and methods for producing these polypeptide molecules.
    Type: Grant
    Filed: July 12, 1994
    Date of Patent: September 16, 1997
    Assignee: Bristol-Myers Squibb Company
    Inventors: Leonard Buckbinder, Randy Talbott, Bernd R. Seizinger, Nikolai Kley